This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe
Home    About    Scholarships    Meetings    Publications    Resources May 3, 2011
ASCLS eNewsBytes
May 3, 2011
ASCLS Quick Links >   Home    About    Scholarships    Meetings    Publications    Resources



Stem cell research can continue to get federal funding, appeals court rules
Los Angeles Times    Share    Share on FacebookTwitterShare on LinkedinE-mail
article
A U.S. appeals court cleared the way for continued federal funding of research using human embryonic stem cells, a ruling that scientists hailed as a victory for medical progress. Stem cells from embryos are believed to hold great promise for treating hard-to-treat illnesses or conditions, such as Parkinson's disease or spinal cord injuries. But the research itself remains controversial because it makes use of cells from early-stage embryos. More
Fact box:
Embryonic stem cells: controversial yet powerful (Reuters)




Researchers discover mechanism that could convert certain cells into insulin-making cells
ScienceDaily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Simply put, people develop diabetes because they don't have enough pancreatic beta cells to produce the insulin necessary to regulate their blood sugar levels. But what if other cells in the body could be coaxed into becoming pancreatic beta cells? Could we potentially cure diabetes? More

HIV infection linked to heart failure risk
Medscape    Share    Share on FacebookTwitterShare on LinkedinE-mail article
HIV infection is a risk factor for heart failure, with ongoing viral replication associated with higher risk, according to the results of a population-based, retrospective study reported in the Archives of Internal Medicine. "Whether human immunodeficiency virus (HIV) infection is a risk factor for heart failure is not clear," according to previous research as cited in the current study. "The presence of coronary heart disease and alcohol consumption in this population may confound this association." More

Qualiris by Stago

Qualiris by Stago is a Web-based External Quality Assessment program used to provide enhanced confidence for your hemostasis testing. Qualiris provides peer-group, result comparisons from a global to a local level. Stago's dedicated experts are available 24/7 to help interpret your results. For more information on Quadfsliris visit www.stago-us.com.


FDA approves abiraterone for metastatic prostate cancer
Medscape    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The U.S. Food and Drug Administration (FDA) has approved abiraterone acetate (Zytiga, Cougar Biotechnology) in combination with prednisone for the treatment of metastatic, castration-resistant prostate cancer in men who have received prior docetaxel chemotherapy. More

Medical laboratory tests for consumers under investigation on 2 continents
DarkDaily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Direct-to-Consumer medical tests are under attack by multiple federal agencies here in the United States, even as authorities in the United Kingdom similarly question the potential of these genetic tests and molecular diagnostic assays to harm and/or mislead consumers. More



Amyloid beta 1-42 linked to outcome after cardiac arrest
Medscape    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A new study using a sensitive assay technology shows a time-dependent rise in amyloid beta 1-42 (Aβ-42) in the blood of patients resuscitated after cardiac arrest. A strong correlation was seen between the rise and fall of Aβ-42 in the hours after arrest and clinical outcomes, suggesting the elevated Aβ-42 level is derived from the brain of these patients. It also suggests this might be used as a marker of damage in the same way that troponins reflect cardiac damage after myocardial infarction. More

Specialists in Bone, Growth, Cartilage, Hypertension & Automation

IDS manufactures and markets specialist Immunoassays for diagnostic and research laboratory testing. These include fully automated and manual assays.


Study ranks food pathogens by cost to society
The Washington Post    Share    Share on FacebookTwitterShare on LinkedinE-mail article
For the first time, researchers used federal data on food-borne illnesses to link the pathogens — bacteria, viruses or parasites — and the foods that most often carry them and then ranked them according to the financial burden they place on society. More



ASCO recommends EGFR testing for NSCLC, but for which patients?
Medscape    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Epidermal growth-factor receptor (EGFR) mutation testing is now recommended by the American Society of Clinical Oncology (ASCO) for patients with advanced nonsmall-cell lung cancer (NSCLC) who are "considering" first-line therapy with the EGFR tyrosine kinase inhibitors (TKIs) erlotinib (Tarceva) and gefitinib (Iressa). More



One in 1,000 newborns develops blood poisoning
HealthDay News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Most cases of bloodstream infections (sepsis) among newborns in the United States are caused by group B streptococci (GBS) and E. coli, a new study finds. Sepsis, also known as blood poisoning, occurs when bacteria invade the bloodstream and cause a system-wide infection. It can lead to serious complications and poses a high risk of death in newborns. More
Triturus - True Open Flexibility
As a leader in fully automated immunoassay testing systems, Grifols USA Diagnostic Division’s premier product, the TRITURUS® ELISA System is an open, fully automated, multi-test and multi-batch immunoassay system. Grifols USA is a major distributor of quality IVD ELISA tests for Infectious Disease, Autoimmune Diseases and many other disease states. Grifols’ Diagnostic products take the complexity out of clinical diagnostic testing.

Contact us at 1-800-379-0957.
CellaVision Automates and Standardizes the Manual Differential

CellaVision introduces CellAtlas®, the perfect way to learn the basics of hematology cell morphology. This App for the Apple iPhone and iPod Touch compliments our digital cell morphology portfolio, and is an educational tool to assist in the recognition and classification of blood cells, by utilizing mini-lectures and cell quizzes.
More
Trust in Cleveland Clinic Laboratories
Cleveland Clinic Laboratories is a full-service, national reference lab dedicated to providing world class care. We have a dedicated staff of more than 1,300 employees, including board-certified subspecialty pathologists, PhDs, technologists, technicians, and support personnel. Cleveland Clinic Laboratories is proud to serve hospitals, outpatient facilities and physician offices worldwide. For more information, please visit clevelandcliniclabs.com.
This edition of the ASCLS eNewsBytes was sent to ##Email##. To unsubscribe, click here.

Did someone forward this edition to you? Subscribe here - it's free!

Advertise

Colby Horton, Vice President of Publishing
469.420.2601

Download Media Kit

To contribute news to the ASCLS eNewsBytes, contact Yvette Craig, Senior Content Editor
469.420.2641.

Recent Issues

  • Dedicated - Bio-Rad - April
  • April 26, 2011
  • April 19, 2011
  • April 12, 2011
  • April 5, 2011
  •  RSS Feed
    Most popular articles